Stage II Prostate Cancer AJCC v8

general

Stage IIC includes: (T1-2, N0, M0, PSA less than 20, Grade Group 3); (T1-2, N0, M0, PSA less than 20, Grade Group 4). T1: Prostate cancer with clinically inapparent tumor that is not palpable. T2: Prostate cancer in which the tumor is palpable and confined within the prostate. N0: Prostate cancer with no positive regional nodes. M0: Prostate cancer without evidence of distant metastasis. Grade Group 3: Gleason Score 7, Gleason Pattern 4+3. Grade Group 4: Gleason Score 8, Gleason Pattern 4+4. (AJ

48

Centers

54

Active Trials

$3.7B

Cancer Funding

Specific Cancer Types(2)

Top Centers for Stage II Prostate Cancer AJCC v8(48)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
73.2
2
NCI Comprehensive
High-Volume Research Center
72.0
3
NCI Comprehensive
Active Research Program
65.9
465.9
5
NCI Comprehensive
Active Research Program
65.9
6
NCI Comprehensive
Active Research Program
65.9
7
NCI Comprehensive
Active Research Program
65.9
8
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
65.9
9
Active Research Program
65.9
10
Active Research Program
65.9
11
Active Research Program
65.9
12
NCI Comprehensive
Active Research Program
45.3
13
NCI Comprehensive
Active Research Program
45.3
14
NCI Comprehensive
Active Research Program
45.3
15
NCI Comprehensive
Active Research Program
45.3
16
NCI Comprehensive
Active Research Program
45.3
17
NCI Comprehensive
Active Research Program
45.3
18
NCI Comprehensive
Active Research Program
45.3
19
NCI Comprehensive
Active Research Program
45.3
20
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
45.3
21
NCI Comprehensive
Active Research Program
45.3
22
NCI Clinical
Active Research Program
45.3
23
NCI Comprehensive
Active Research Program
45.3
24
Active Research Program
45.3
25
NCI Clinical
Active Research Program
45.3
26
Active Research Program
45.3
27
NCI Clinical
Active Research Program
45.3
28
Active Research Program
45.3
29
Active Research Program
45.3
30
NCI Comprehensive
Active Research Program
45.3
31
Active Research Program
45.3
32
Active Research Program
45.3
33
Active Research Program
45.3
34
Active Research Program
45.3
35
Active Research Program
45.3
36
Active Research Program
45.3
37
NCI Comprehensive
29.5
38
39
40
NCI Comprehensive
41
NCI Comprehensive
42
NCI Comprehensive
43
NCI Comprehensive
44
45
46
47
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
48

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →